The market performance of Prime Medicine Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $9.77 on 02/27/24, with the lowest value for the same timeframe being $2.56, recorded on 12/19/24.
52-week price history of PRME Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Prime Medicine Inc’s current trading price is -71.03% away from its 52-week high, while its distance from the 52-week low is 10.55%. The stock’s price range during this period has fluctuated between $2.56 and $9.77. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.76 million for the day, which was evidently lower than the average daily volume of 1.09 million over the last three months.
Financial Performance and Market Capitalization
Prime Medicine Inc (PRME) has experienced a quarterly decline of -32.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 371.19M and boasts a workforce of 234 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.48, with a change in price of -1.03. Similarly, Prime Medicine Inc recorded 1,422,054 in trading volume during the last 100 days, posting a change of -26.68%.
PRME Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.19.
PRME Stock Stochastic Average
Prime Medicine Inc’s raw stochastic average for the past 50 days is currently at 13.99%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 20.83%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 38.89% and 50.58%, respectively.
PRME Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -3.08%.However, over the last six months, we can see a stronger performance of -49.55%. Over the last 30 days, the price of PRME has fallen by 2.54%. And in the last five days, it has fallen by -2.75%.
